Compound Edaravone Injection for Acute Ischemic Stroke
Status:
Completed
Trial end date:
2015-02-01
Target enrollment:
Participant gender:
Summary
1. To investigate the efficacy and safety of multi-doses Compound Edaravone Injection
versus Edaravone Injection for acute ischemic stroke patients;
2. To provide evidence for the design of Compound Edaravone Injection Phase III trial.